The incidence of breast cancer is higher in urban areas, especially the metropolitan cities where it is now the leading female cancer and is the second most common cancer after cervix in rural and semi-urban areas. As for other cancers, late-stage presentation is also a common scenario for breast cancer. The overall Global Breast Cancer Treatment Market is expected to grow at a significant compound CAGR rate of 12.9% from USD 17.26 bn in 2018 to USD 45.52 bn in 2026. This expansion in breast cancer is due to the rising preference for targeted therapy approach in breast cancer treatment and development in pharmacology & cancer biology are driving the market growth. However, outdated of patented drugs is restraining the breast cancer market growth. However, increasing the number of pipeline drugs are providing ample opportunities for Breast cancer market.
Global Breast Cancer: Key Segments
Type: – Among all Types, Chemotherapy segment occupied the largest market share, owing to the factors, for example, assaulting all cells that are developing rapidly and expanded expense related with the medications resulting financial burden. Additionally, unwanted chemotherapy responses and foundation of protection from medications resulting in multi-drug resistance are the major limiting variable in chemotherapy usage.
Region Type: – Breast cancer market covers North America, Europe, Asia Pacific and the Rest of the world. Rising responsiveness and occurrence of recognized R&D foundation are among the key variables adding to the development of the market in North America. Also, the occurrence of key players, for example, AbbVie, Inc, Celgene Corporation, Merck & Co., Inc and Pfizer, Inc. in the territory is predictable to spur the growth. Growing awareness about the advantages of early detection of cancer has fuel the U.S.-based companies to make extensive investments in the advancement of targeted therapy drugs
Key Market Drivers: –
Global Breast Cancer Market Trends
- Rising prevalence of breast cancer:
Growing prevalence of breast cancer growth relating to variables, for example, delayed presentation to endogenous estrogens, early menarche, late age at first childbirth and late menopause will be a high effect rendering factor for the market growth.
Global Breast Cancer Market: Restraints
- Easily availability of drugs:
Moreover, the expanded and simple accessibility of generic medications in the worldwide market, which has enormously expanded the dimension of rivalry in the market, could hamper its development to a certain extent.
Global Breast Cancer Market: Opportunities and Challenges
- The rise in R&D activities related to breast cancer drugs could drive market
The market is also profiting by the rising number of pharmaceutical organizations plowing in expanded assets into R&D exercises identified with bosom malignancy drugs and various new sellers concentrating on the assembling of nonexclusive medications to serve a tremendous pool of neglected requests crosswise over rising economies. Besides, the improvement of modified companion diagnostic models for patients as indicated by the molecular qualities of the cancer growth is relied upon to give promising development opportunities to the market.
- Complications associated with chemotherapy:
Chemotherapy works on dynamic cells. Active cells will be cells that are developing and partitioning into additional as usual kind of cell. cancer growth cells are dynamic, yet so are some healthy cells. These incorporate cells in the mouth, digestive system, hair follicles, and blood. Side effects happen when chemotherapy harms these healthy cells this will cause a threat to the market.
Breast Cancer Market Based on Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- Chemotherapy Drugs
- Hormone Therapy Drugs
- Targeted Therapy Drugs
- Other Therapeutic Drugs
Breast Cancer Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- North America
- Europe
- APAC
- LAMEA
Breast Cancer Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)
- Amgen
- Celldex Therapeutics.
- MacroGenics Inc.
- Genentech, Inc.
- AbbVie, Inc.
- AstraZeneca
- Hoffman-La Roche Pvt. Ltd
- Genzyme Corporation
- Astellas Pharma Inc.
- Celgene Corporation
About Us
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global breast cancer and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to take better business decisions towards attaining market leadership.
Contact
Optima Insights
Mr Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Email: chuksg@optimainsights.org
https://www.optimainsights.org